OCONEE MEMORIAL HOSPITAL
- Type
- Teaching hospital
- Where
- SENECA, SC
- Medicare CCN
- 420009
- Received
- $490,936 in 90 records, 2019 ($104,942 general, $385,993 research)
- Source
- CMS Open Payments search ↗
On this site
- Federal award recipient: OCONEE MEMORIAL HOSPITAL INC Fuzzy (name and state)
- Lobbying client: OCONEE MEMORIAL HOSPITAL Fuzzy (name and state)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2019 | General payment | 32 | $104,942 |
| 2019 | Research payment | 58 | $385,993 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| ABBVIE INC. | 13 | $95,742 | 2019 |
| EMD Serono, Inc. | 5 | $86,227 | 2019 |
| AstraZeneca Pharmaceuticals LP | 4 | $80,440 | 2019 |
| Smith+Nephew, Inc. | 4 | $57,069 | 2019 |
| Abbott Laboratories | 10 | $45,552 | 2019 |
| Cook Research Incorporated | 17 | $33,211 | 2019 |
| Stryker Corporation | 7 | $15,200 | 2019 |
| AstraZeneca UK Limited | 3 | $13,224 | 2019 |
| SANOFI US SERVICES INC. | 2 | $12,500 | 2019 |
| Hill-Rom Company, Inc | 8 | $11,663 | 2019 |
| Inari Medical, Inc. | 1 | $10,700 | 2019 |
| Acerta Pharma LLC | 2 | $7,106 | 2019 |
| Cook Incorporated | 3 | $4,410 | 2019 |
| Siemens Medical Solutions USA, Inc. | 2 | $4,000 | 2019 |
| GENZYME CORPORATION | 3 | $3,539 | 2019 |
| Linvatec Corporation | 1 | $3,348 | 2019 |
| ACELL, INC. | 1 | $2,000 | 2019 |
| ABIOMED | 1 | $1,500 | 2019 |
| KCI USA, Inc. | 1 | $1,500 | 2019 |
| SANOFI-AVENTIS U.S. LLC | 1 | $1,500 | 2019 |
| GE HEALTHCARE | 1 | $500 | 2019 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 58 | $385,993 |
| Grant | 5 | $62,348 |
| Gift | 9 | $17,270 |
| Travel and Lodging | 6 | $9,984 |
| Space rental or facility fees (teaching hospital only) | 5 | $5,750 |
| Charitable Contribution | 3 | $4,410 |
| Education | 2 | $3,500 |
| Food and Beverage | 2 | $1,679 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2019-12-31 | Stryker Corporation | $2,978 | Gift | In-kind items and services | SURG - REMB Device, SURGICAL | 2019 | |
| 2019-12-31 | Stryker Corporation | $2,542 | Gift | In-kind items and services | SURG - SYSTEM 7 Device, SURGICAL | 2019 | |
| 2019-12-31 | Stryker Corporation | $1,983 | Gift | In-kind items and services | NSE - HIGH SPEED DRILLS Device, NEURO SPINE ENT | 2019 | |
| 2019-12-31 | Stryker Corporation | $1,983 | Gift | In-kind items and services | NSE - HIGH SPEED DRILLS Device, NEURO SPINE ENT | 2019 | |
| 2019-12-31 | Stryker Corporation | $1,932 | Gift | In-kind items and services | SURG - REMB Device, SURGICAL | 2019 | |
| 2019-12-31 | Stryker Corporation | $1,898 | Gift | In-kind items and services | SURG - REMB Device, SURGICAL | 2019 | |
| 2019-12-31 | Stryker Corporation | $1,881 | Gift | In-kind items and services | SURG - REMB Device, SURGICAL | 2019 | |
| 2019-12-31 | Acerta Pharma LLC | $383 | Research payment | In-kind items and services | CALQUENCE Drug, Oncology | A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreat | 2019 |
| 2019-12-31 | AstraZeneca Pharmaceuticals LP | $118 | Research payment | In-kind items and services | CALQUENCE Drug, Oncology | A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreat | 2019 |
| 2019-12-31 | AstraZeneca UK Limited | $101 | Research payment | In-kind items and services | This is an open label non randomised study designed to provide continued access to AZD1775 for eligible patients with ad | 2019 | |
| 2019-12-30 | ABBVIE INC. | $531 | Research payment | Cash or cash equivalent | M16-074 | 2019 | |
| 2019-12-18 | Cook Research Incorporated | $1,425 | Research payment | Cash or cash equivalent | A Double-blind, Randomized, Controlled Trial Comparing the Safety and Effic | 2019 | |
| 2019-12-18 | Cook Research Incorporated | $860 | Research payment | Cash or cash equivalent | A Double-blind, Randomized, Controlled Trial Comparing the Safety and Effic | 2019 | |
| 2019-12-18 | Cook Research Incorporated | $800 | Research payment | Cash or cash equivalent | Cook Medical Self-Expanding Stent Device, Peripheral Intervention | Zilver PTX V Post Market Study in the US | 2019 |
| 2019-12-18 | Cook Research Incorporated | $290 | Research payment | Cash or cash equivalent | Cook Medical Self-Expanding Stent Device, Peripheral Intervention | Zilver PTX V Post Market Study in the US | 2019 |
| 2019-12-09 | SANOFI US SERVICES INC. | $11,600 | Research payment | Cash or cash equivalent | SAR439954 Drug | A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effects of Sotaglifloz | 2019 |
| 2019-12-03 | EMD Serono, Inc. | $2,017 | Research payment | Cash or cash equivalent | MSC2490484A Biological, Oncology | MS201964-0001 | 2019 |
| 2019-12-02 | GENZYME CORPORATION | $250 | Research payment | Cash or cash equivalent | HECTOROL Drug, RARE DISEASE METABOLIC | An Open-Label, Randomized, Parallel Group Study to Assess the Safety and Efficacy of Hectorol (Doxercalciferol Capsules) | 2019 |
| 2019-11-27 | ABBVIE INC. | $3,180 | Research payment | Cash or cash equivalent | M16-074 | 2019 | |
| 2019-11-22 | Smith+Nephew, Inc. | $1,100 | Gift | In-kind items and services | Stravix Biological, Other Advanced Wound Management | 2019 | |
| 2019-11-22 | Smith+Nephew, Inc. | $969 | Gift | In-kind items and services | Stravix Biological, Other Advanced Wound Management | 2019 | |
| 2019-11-01 | EMD Serono, Inc. | $4,546 | Research payment | Cash or cash equivalent | MSC2490484A Biological, Oncology | MS201964-0001 | 2019 |
| 2019-10-30 | ABBVIE INC. | $6,932 | Research payment | Cash or cash equivalent | M16-074 | 2019 | |
| 2019-10-21 | Abbott Laboratories | $1,500 | Research payment | Cash or cash equivalent | Xience V coronary stent system Device, Vascular | DAPT study | 2019 |
| 2019-10-21 | Abbott Laboratories | $640 | Research payment | Cash or cash equivalent | Xience V coronary stent system Device, Vascular | DAPT study | 2019 |
| 2019-10-15 | Hill-Rom Company, Inc | $2,145 | Travel and Lodging | In-kind items and services | Hill-Rom Heart and Respiration Rate Monitoring System powered by EarlySense Device, Breathing Frequency Monitor | 2019 | |
| 2019-10-15 | Hill-Rom Company, Inc | $1,310 | Travel and Lodging | In-kind items and services | Hill-Rom Heart and Respiration Rate Monitoring System powered by EarlySense Device, Breathing Frequency Monitor | 2019 | |
| 2019-10-15 | Hill-Rom Company, Inc | $606 | Food and Beverage | In-kind items and services | Hill-Rom Heart and Respiration Rate Monitoring System powered by EarlySense Device, Breathing Frequency Monitor | 2019 | |
| 2019-10-15 | Hill-Rom Company, Inc | $375 | Travel and Lodging | In-kind items and services | Hill-Rom Heart and Respiration Rate Monitoring System powered by EarlySense Device, Breathing Frequency Monitor | 2019 | |
| 2019-10-14 | Smith+Nephew, Inc. | $45,000 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-10-14 | Siemens Medical Solutions USA, Inc. | $1,500 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-10-09 | KCI USA, Inc. | $1,500 | Education | Cash or cash equivalent | VAC VERAFLO Device, DEVICES | 2019 | |
| 2019-10-03 | Siemens Medical Solutions USA, Inc. | $2,500 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-09-30 | ABBVIE INC. | $11,229 | Research payment | Cash or cash equivalent | M16-074 | 2019 | |
| 2019-09-18 | Abbott Laboratories | $22,936 | Research payment | Cash or cash equivalent | Heart Failure Device, Cardiac Arrhythmias and Heart Failure | Hemodynamic Guided Monitoring in Heart Failure (HF) Trial (GUIDE-HF) | 2019 |
| 2019-09-18 | Abbott Laboratories | $3,188 | Research payment | Cash or cash equivalent | Heart Failure Device, Cardiac Arrhythmias and Heart Failure | Hemodynamic Guided Monitoring in Heart Failure (HF) Trial (GUIDE-HF) | 2019 |
| 2019-09-13 | Cook Research Incorporated | $2,141 | Research payment | Cash or cash equivalent | A Double-blind, Randomized, Controlled Trial Comparing the Safety and Effic | 2019 | |
| 2019-09-13 | Cook Research Incorporated | $460 | Research payment | Cash or cash equivalent | A Double-blind, Randomized, Controlled Trial Comparing the Safety and Effic | 2019 | |
| 2019-09-11 | Cook Research Incorporated | $1,350 | Research payment | Cash or cash equivalent | Cook Medical Self-Expanding Stent Device, Peripheral Intervention | Zilver PTX V Post Market Study in the US | 2019 |
| 2019-09-11 | Cook Research Incorporated | $100 | Research payment | Cash or cash equivalent | Cook Medical Self-Expanding Stent Device, Peripheral Intervention | Zilver PTX V Post Market Study in the US | 2019 |
| 2019-09-09 | GENZYME CORPORATION | $689 | Research payment | Cash or cash equivalent | HECTOROL Drug, RARE DISEASE METABOLIC | An Open-Label, Randomized, Parallel Group Study to Assess the Safety and Efficacy of Hectorol (Doxercalciferol Capsules) | 2019 |
| 2019-09-06 | EMD Serono, Inc. | $61,812 | Research payment | Cash or cash equivalent | MSC2490484A Biological, Oncology | MS201964-0001 | 2019 |
| 2019-08-30 | ABBVIE INC. | $5,894 | Research payment | Cash or cash equivalent | M16-074 | 2019 | |
| 2019-08-22 | AstraZeneca Pharmaceuticals LP | $40,938 | Research payment | Cash or cash equivalent | IMFINZI Drug, Oncology | A Phase II Fixed Dose Study of Durvalumab in Combination with Tremelimumab in Subjects with Advanced Rare Solid Tumors | 2019 |
| 2019-08-22 | Abbott Laboratories | $8,000 | Research payment | Cash or cash equivalent | Heart Failure Device, Cardiac Arrhythmias and Heart Failure | Hemodynamic Guided Monitoring in Heart Failure (HF) Trial (GUIDE-HF) | 2019 |
| 2019-08-13 | Cook Research Incorporated | $750 | Research payment | Cash or cash equivalent | Cook Medical Self-Expanding Stent Device, Peripheral Intervention | Zilver PTX V Post Market Study in the US | 2019 |
| 2019-08-13 | Cook Research Incorporated | $290 | Research payment | Cash or cash equivalent | Cook Medical Self-Expanding Stent Device, Peripheral Intervention | Zilver PTX V Post Market Study in the US | 2019 |
| 2019-08-09 | AstraZeneca UK Limited | $1,795 | Research payment | Cash or cash equivalent | This is an open label non randomised study designed to provide continued access to AZD1775 for eligible patients with ad | 2019 | |
| 2019-08-08 | ABBVIE INC. | $658 | Research payment | Cash or cash equivalent | M14-064 | 2019 | |
| 2019-08-07 | Cook Incorporated | $3,250 | Charitable Contribution | In-kind items and services | SPECIALTY Device, SPECIALTY CATHETERS | 2019 | |
| 2019-08-07 | Cook Incorporated | $790 | Charitable Contribution | In-kind items and services | HYDROPHILIC Device, WIRE GUIDES | 2019 | |
| 2019-08-07 | Cook Incorporated | $370 | Charitable Contribution | In-kind items and services | DIAGNOSTIC Device, WIRE GUIDES | 2019 | |
| 2019-07-30 | ABBVIE INC. | $45,267 | Research payment | Cash or cash equivalent | M16-074 | 2019 | |
| 2019-07-30 | AstraZeneca Pharmaceuticals LP | $2,067 | Research payment | Cash or cash equivalent | CALQUENCE Drug, Oncology | A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreat | 2019 |
| 2019-07-23 | EMD Serono, Inc. | $1,537 | Research payment | Cash or cash equivalent | MSC2490484A Biological, Oncology | MS201964-0001 | 2019 |
| 2019-07-02 | Abbott Laboratories | $5,000 | Research payment | Cash or cash equivalent | Xience V coronary stent system Device, Vascular | DAPT study | 2019 |
| 2019-07-02 | Abbott Laboratories | $2,000 | Research payment | Cash or cash equivalent | Xience V coronary stent system Device, Vascular | DAPT study | 2019 |
| 2019-07-01 | EMD Serono, Inc. | $16,312 | Research payment | Cash or cash equivalent | MSC2490484A Biological, Oncology | MS201964-0001 | 2019 |
| 2019-06-13 | Cook Research Incorporated | $2,535 | Research payment | Cash or cash equivalent | A Double-blind, Randomized, Controlled Trial Comparing the Safety and Effic | 2019 | |
| 2019-06-13 | Cook Research Incorporated | $980 | Research payment | Cash or cash equivalent | A Double-blind, Randomized, Controlled Trial Comparing the Safety and Effic | 2019 | |
| 2019-05-31 | Smith+Nephew, Inc. | $10,000 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-05-29 | ABBVIE INC. | $656 | Research payment | Cash or cash equivalent | M15-819 | 2019 | |
| 2019-05-16 | Hill-Rom Company, Inc | $4,026 | Travel and Lodging | In-kind items and services | Hill-Rom Heart and Respiration Rate Monitoring System powered by EarlySense Device, Breathing Frequency Monitor | 2019 | |
| 2019-05-16 | Hill-Rom Company, Inc | $1,526 | Travel and Lodging | In-kind items and services | Hill-Rom Heart and Respiration Rate Monitoring System powered by EarlySense Device, Breathing Frequency Monitor | 2019 | |
| 2019-05-16 | Hill-Rom Company, Inc | $1,073 | Food and Beverage | In-kind items and services | Hill-Rom Heart and Respiration Rate Monitoring System powered by EarlySense Device, Breathing Frequency Monitor | 2019 | |
| 2019-05-16 | Hill-Rom Company, Inc | $600 | Travel and Lodging | In-kind items and services | Hill-Rom Heart and Respiration Rate Monitoring System powered by EarlySense Device, Breathing Frequency Monitor | 2019 | |
| 2019-05-15 | Inari Medical, Inc. | $10,700 | Research payment | Cash or cash equivalent | ClotTriever Device, Venous Thrombectomy | ClotTriever Outcomes (CLOUT) Registry | 2019 |
| 2019-05-08 | Cook Research Incorporated | $4,500 | Research payment | Cash or cash equivalent | A Double-blind, Randomized, Controlled Trial Comparing the Safety and Effic | 2019 | |
| 2019-05-06 | AstraZeneca UK Limited | $11,327 | Research payment | Cash or cash equivalent | The purpose of this study is to determine whether AZD1775 has any effect on the pharmacokinetics PK of three compounds | 2019 | |
| 2019-05-02 | Abbott Laboratories | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Xience V coronary stent system Device, Vascular | 2019 | |
| 2019-05-01 | ACELL, INC. | $2,000 | Education | Cash or cash equivalent | 2019 | ||
| 2019-04-29 | ABBVIE INC. | $6,391 | Research payment | Cash or cash equivalent | M16-074 | 2019 | |
| 2019-04-22 | GENZYME CORPORATION | $2,600 | Research payment | Cash or cash equivalent | HECTOROL Drug, RARE DISEASE METABOLIC | An Open-Label, Randomized, Parallel Group Study to Assess the Safety and Efficacy of Hectorol (Doxercalciferol Capsules) | 2019 |
| 2019-03-31 | Abbott Laboratories | $38 | Research payment | In-kind items and services | Heart Failure Device, Cardiac Arrhythmias and Heart Failure | Hemodynamic Guided Monitoring in Heart Failure (HF) Trial (GUIDE-HF) | 2019 |
| 2019-03-27 | Cook Research Incorporated | $8,150 | Research payment | Cash or cash equivalent | Zilver PTX V Post Market Study in the US | 2019 | |
| 2019-03-27 | Cook Research Incorporated | $1,930 | Research payment | Cash or cash equivalent | Zilver PTX V Post Market Study in the US | 2019 | |
| 2019-03-25 | ABBVIE INC. | $1,859 | Research payment | Cash or cash equivalent | M14-064 | 2019 | |
| 2019-03-25 | SANOFI US SERVICES INC. | $900 | Research payment | Cash or cash equivalent | HECTOROL Drug, RARE DISEASE METABOLIC | An Open-Label, Randomized, Parallel Group Study to Assess the Safety and Efficacy of Hectorol? (Doxercalciferol Capsules | 2019 |
| 2019-03-14 | Cook Research Incorporated | $3,769 | Research payment | Cash or cash equivalent | A Double-blind, Randomized, Controlled Trial Comparing the Safety and Effic | 2019 | |
| 2019-03-14 | Cook Research Incorporated | $2,880 | Research payment | Cash or cash equivalent | A Double-blind, Randomized, Controlled Trial Comparing the Safety and Effic | 2019 | |
| 2019-02-27 | ABBVIE INC. | $2,115 | Research payment | Cash or cash equivalent | M14-064 | 2019 | |
| 2019-02-25 | AstraZeneca Pharmaceuticals LP | $37,316 | Research payment | Cash or cash equivalent | IMFINZI Drug, Oncology | MEDI4736 anti-PD-L1 mab Solid Tumor-MEDI4736 Basket Study (Ph2a) | 2019 |
| 2019-02-25 | Linvatec Corporation | $3,348 | Grant | In-kind items and services | ABC HANDPIECES Device, GENERAL SURGERY | 2019 | |
| 2019-02-21 | Acerta Pharma LLC | $6,722 | Research payment | Cash or cash equivalent | CALQUENCE Drug, Oncology | A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreat | 2019 |
| 2019-02-21 | GE HEALTHCARE | $500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Device, ULTRASOUND | 2019 | |
| 2019-02-01 | ABBVIE INC. | $7,443 | Research payment | Cash or cash equivalent | M14-064 | 2019 | |
| 2019-01-31 | Abbott Laboratories | $750 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Cardiovascular- Research only Device, Cardiac Arrhythmias and Heart Failure | 2019 | |
| 2019-01-29 | ABBVIE INC. | $3,581 | Research payment | Cash or cash equivalent | M16-074 | 2019 | |
| 2019-01-26 | SANOFI-AVENTIS U.S. LLC | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | PRALUENT Drug, CARDIOVASCULAR | 2019 | |
| 2019-01-11 | ABIOMED | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Impella Device, Cardiology/Vascular Diseases | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Seneca, SC, county Oconee County, SC, state South Carolina; placed by its city name.
| Measure | Place (city or town) Seneca, SC | County Oconee County, SC | State South Carolina |
|---|---|---|---|
| Population B01003 | 8,993 | 80,469 | 5,296,225 |
| Population, 2020 census P1 | 8,850 | 78,607 | 5,118,425 |
| Median age B01002 | 39.6 | 47.3 | 40.2 |
| Under 18 B01001 | 18.5% | 19.1% | 21.4% |
| 65 and over B01001 | 20.4% | 24.9% | 18.9% |
| Households B11001 | 4,082 | 34,515 | 2,117,989 |
| Foreign born B05002 | 2.6% | 4.2% | 5.8% |
| Median household income B19013 | $52,022 | $62,388 | $69,324 |
| Median family income B19113 | $74,864 | $80,443 | $86,707 |
| Per capita income B19301 | $34,204 | $39,360 | $39,236 |
| Poverty rate B17001 | 22.1% | 17.6% | 14.1% |
| Unemployment rate B23025 | 8.9% | 5.9% | 4.9% |
| Civilian labor force B23025 | 4,606 | 35,647 | 2,560,429 |
| Mean commute (minutes) B08013 | 16.0 | 23.9 | 25.6 |
| Bachelor's degree or higher B15003 | 29.1% | 28.7% | 32.1% |
| Housing units B25001 | 4,648 | 42,100 | 2,443,039 |
| Owner-occupied B25003 | 51.4% | 76.2% | 71.9% |
| Renters B25003 | 48.6% | 23.8% | 28.1% |
| Median home value B25077 | $240,000 | $237,100 | $259,000 |
| Median gross rent B25064 | $807 | $881 | $1,180 |
| White, not Hispanic B03002 | 72.8% | 83.1% | 61.9% |
| Black B03002 | 17.4% | 5.2% | 24.6% |
| Hispanic or Latino B03002 | 6.4% | 6.2% | 7.4% |
| Asian B03002 | 0.8% | 0.7% | 1.7% |
| American Indian and Alaska Native B03002 | 0.8% | 0.4% | 0.2% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Seneca, SC.
Comments